The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed nutritional journals, pharmaceutical publications, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA), European Food Safety Authority (EFSA), National Medical Products Administration (NMPA/China), Health Canada, Therapeutic Goods Administration (TGA/Australia), Office of Dietary Supplements (National Institutes of Health), World Health Organization (WHO) Global Health Observatory, Food and Agriculture Organization (FAO) FAOSTAT, US Department of Agriculture (USDA) National Agricultural Statistics Service, United Nations Comtrade Database, International Trade Centre (ITC) Trade Map, Council for Responsible Nutrition (CRN), International Alliance of Dietary Supplement Associations (IADSA), European Federation of Associations of Health Product Manufacturers (EHPM), International Society for Nutraceuticals and Functional Foods (ISNFF), American Botanical Council, National Center for Biotechnology Information (NCBI/PubMed), and national customs statistics from China, India, Germany, and the United States. These sources were used to collect production volume statistics, import/export trade data, regulatory approval status for novel vitamin C derivatives, dietary reference intake studies, functional food formulation trends, and competitive landscape analysis for pharmaceutical-grade ascorbic acid, food fortification ingredients, and cosmetic-grade vitamin C derivatives.